.png)
TOPLINE: High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively), a new trial showed. METHODOLOGY: This multicentre, open-label, randomised, non-inferiority trial across eight countries, conducted from 2021 to 2024, included biopsy-naive adult men with clinical suspicion of prostate cancer due to elevated prostate-specific ...
Copyright © 2025 globalnews. All Rights Reserved
